STOCK TITAN

RPID (NASDAQ: RPID) insider files to sell 4,610 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of RPID filed a notice of intent to sell 4,610 shares of Class A stock under Rule 144. The planned sale, valued at $17,438.25, is to be executed through Fidelity Brokerage Services LLC on the NASDAQ around February 9, 2026. These shares were acquired on February 6, 2026 through restricted stock vesting as compensation from the issuer, indicating they are recently vested equity awards being sold into the market.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for RPID disclose?

The Form 144 filing for RPID discloses a shareholder’s intention to sell 4,610 Class A shares under Rule 144. The filing outlines share quantity, market value, acquisition method, planned sale date, and the broker and exchange that will be used for the transaction.

How many RPID shares are planned to be sold and at what value?

The filing states an intention to sell 4,610 Class A shares of RPID stock. The aggregate market value for this planned sale is reported as $17,438.25, based on the market price at the time used in the notice.

How and when were the RPID shares being sold under Form 144 acquired?

The 4,610 RPID Class A shares were acquired on February 6, 2026 through restricted stock vesting. The filing notes the nature of the acquisition as compensation from the issuer, indicating these are recently vested equity compensation shares rather than open-market purchases.

Which broker and exchange will handle the planned RPID share sale?

The Form 144 indicates the seller plans to use Fidelity Brokerage Services LLC as the broker. The shares are expected to be sold on the NASDAQ stock market, providing a clear view of where the transaction is intended to occur.

What is the approximate date of the RPID share sale under this Form 144?

The notice lists an approximate sale date of February 9, 2026 for the 4,610 RPID Class A shares. This date reflects when the shareholder expects to begin selling, subject to market conditions and Rule 144 requirements.

What type of transaction is behind the RPID shares now being sold?

The filing identifies the source of the shares as restricted stock vesting received as compensation from the issuer on February 6, 2026. This means the seller is monetizing equity awards rather than disposing of long-held, open-market purchases.
Rapid Micro Biosystems, Inc.

NASDAQ:RPID

RPID Rankings

RPID Latest News

RPID Latest SEC Filings

RPID Stock Data

171.53M
35.45M
9.6%
59.55%
0.77%
Medical Devices
Laboratory Analytical Instruments
Link
United States
LEXINGTON